Microbes

© GettyImages/Feodora Chiosea

US microbiome-focused Ascus generates $46m in Series B round

By Jane Byrne

US endomicrobial-based products producer, Ascus Bioscience, said the US$46m it has secured in a Series B funding round leaves it well positioned to continue expanding its sales and servicing teams, and to advance new and existing products in its product...